Outpatient treatment with lisocabtagene maraleucel (liso-cel) in 3 ongoing clinical studies in relapsed/refractory (R/R) large B cell non-Hodgkin lymphoma (NHL), including second-line transplant noneligible (TNE) patients: Transcend NHL 001, outreach, and PILOT Meeting Abstract
| Authors: | Bachier, C. R.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Sehgal, A.; Godwin, J.; Hildebrandt, G. C.; Siddiqi, T.; Stevens, D.; Farazi, T.; Kostic, A.; Trede, N. S.; Wang, L.; Lymp, J.; Thelen, T.; Ogasawara, K.; Maloney, D. G. |
| Abstract Title: | Outpatient treatment with lisocabtagene maraleucel (liso-cel) in 3 ongoing clinical studies in relapsed/refractory (R/R) large B cell non-Hodgkin lymphoma (NHL), including second-line transplant noneligible (TNE) patients: Transcend NHL 001, outreach, and PILOT |
| Meeting Title: | Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 26 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2020 Feb 19-23 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-03-01 |
| Start Page: | S25 |
| End Page: | S26 |
| Language: | English |
| ACCESSION: | WOS:000516887900030 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2019.12.093 |
| Notes: | Meeting Abstract: 29 -- Source: Wos |
